A Study of Laquinimod Eye-drops in Healthy Participants
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1 randomized, double-masked, placebo-controlled study performed with healthy
participants to assess the safety and tolerability of laquinimod eye-drops.